Tenderwize
Retour à la recherche

Open House Discount Agreements for Axitinib, ATC L01EK01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 249 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Axitinib, ATC L01EK01

60/100

Score d'opportunité

PromisingLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

20 / 100

Facteurs de risque

Agreements automatically lapse if a national or regional discount contract for the same substance is concluded during t...

Paper submission requires two originals and must arrive by 10th if fax/email used; incorrect submission may delay or pr...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Open-house model for non-exclusive discount agreements on Axitinib (ATC L01EK01)
  • All pharmaceutical companies meeting eligibility can participate
Afficher le résumé complet

This is an open-house model, not a competitive procurement. AOK Bayern invites all interested pharmaceutical companies to sign non-exclusive discount agreements for the active substance Axitinib (ATC L01EK01) under §130a Abs. 8 SGB V. All companies meeting eligibility (submitted declaration of reliability) can join. Contracts run from 01.07.2025 to 30.06.2027. No estimated value provided. Submission deadlines: any time until 05.05.2027, but to start at a specific month, documents must be received by the 5th of that month. Documents can be submitted in paper or electronically with qualified electronic signature.

Risques

Agreements automatically lapse if a national or regional discount contract for the same substance is concluded during t...

Paper submission requires two originals and must arrive by 10th if fax/email used; incorrect submission may delay or pr...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical company

Administrative

  • Submit signed contract, annex specifying medicines, and signed declaration of reliability
  • Documents in German or with German translation

Les exigences peuvent être incomplètes.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Axitinib, ATC L01EK01

Non-exclusive discount agreements for the active substance Axitinib. All eligible pharmaceutical companies can join at any time during the contract period. Contracts are identical and non-negotiable. Early termination possible with one-month notice. Agreements automatically lapse if a national or regional discount contract for the same substance is concluded.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jun 2025 - Jun 2027

Catégorie

Pharmaceutical products

Date limite

Deadline May 05, 2027

Détails de la procédure

Date de publication
15 May 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
317253-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30